abstract |
To produce a crystalline form of a compound (1) that enables a formulation that meets the stringent requirements and standards of pharmaceuticals. The present invention relates to a novel crystalline form of compound (1), and its sodium salt, its preparation method, its pharmaceutical composition, and their use in the treatment of hepatitis C virus (HCV) infection. [Selection] Figure 1 |